Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Edmonston

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Nature Reviews. Nephrology|September 15, 2019
FGF23 at the crossroads of phosphate, iron economy and erythropoiesisDaniel Edmonston, Myles Wolf
Nature Reviews. Cardiology|July 14, 2023
FGF23 and klotho at the intersection of kidney and cardiovascular diseaseDaniel Edmonston, Alexander Grabner, Myles Wolf
Journal of the American Heart Association|August 23, 2023
Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney DiseaseDaniel Edmonston, Tamara Isakova, Myles Wolf, et al.
Advances in Chronic Kidney Disease|October 13, 2018
Working Toward an Improved Understanding of Chronic Cardiorenal Syndrome Type 4Daniel Edmonston, Jessica D Morris, John P Middleton
Journal of the American Society of Nephrology : JASN|March 12, 2026
Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney FailureBenjamin Catanese, Cameron Miller, Myles Wolf, et al.
Journal of Managed Care & Specialty Pharmacy|November 30, 2020
Prescribing rates and characteristics of recipients of tenofovir-containing regimens before and after market entry of tenofovir alafenamideAnna Hung, Matthew Sinclair, Marion Hemmersbach-Miller, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 7, 2024
Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyDaniel Edmonston, Michaela A A Fuchs, Emily J Burke, et al.
JACC. Heart Failure|May 4, 2019
Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal DiseaseAaron M Hein, Julia J Scialla, Daniel Edmonston, et al.
Clinical Cardiology|August 21, 2018
The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomesKelly R McHugh, Adam D DeVore, Robert J Mentz, et al.
The Annals of Pharmacotherapy|November 4, 2025
Impact of Treatment Modalities on Intensive Care Unit Length of Stay for Patients Admitted With Severe HyponatremiaWilliam H Harris, Komal Safdar, Frances Hung, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nature Reviews. Nephrology|September 15, 2019
FGF23 at the crossroads of phosphate, iron economy and erythropoiesisDaniel Edmonston, Myles Wolf
Nature Reviews. Cardiology|July 14, 2023
FGF23 and klotho at the intersection of kidney and cardiovascular diseaseDaniel Edmonston, Alexander Grabner, Myles Wolf
Journal of the American Heart Association|August 23, 2023
Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney DiseaseDaniel Edmonston, Tamara Isakova, Myles Wolf, et al.
Advances in Chronic Kidney Disease|October 13, 2018
Working Toward an Improved Understanding of Chronic Cardiorenal Syndrome Type 4Daniel Edmonston, Jessica D Morris, John P Middleton
Journal of the American Society of Nephrology : JASN|March 12, 2026
Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney FailureBenjamin Catanese, Cameron Miller, Myles Wolf, et al.
Journal of Managed Care & Specialty Pharmacy|November 30, 2020
Prescribing rates and characteristics of recipients of tenofovir-containing regimens before and after market entry of tenofovir alafenamideAnna Hung, Matthew Sinclair, Marion Hemmersbach-Miller, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 7, 2024
Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyDaniel Edmonston, Michaela A A Fuchs, Emily J Burke, et al.
JACC. Heart Failure|May 4, 2019
Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal DiseaseAaron M Hein, Julia J Scialla, Daniel Edmonston, et al.
Clinical Cardiology|August 21, 2018
The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomesKelly R McHugh, Adam D DeVore, Robert J Mentz, et al.
The Annals of Pharmacotherapy|November 4, 2025
Impact of Treatment Modalities on Intensive Care Unit Length of Stay for Patients Admitted With Severe HyponatremiaWilliam H Harris, Komal Safdar, Frances Hung, et al.
Pageof 2